Our policy focus: protect patients
At the Partnership for Safe Medicines we advocate for policies that reduce patients' exposure to counterfeit medication. We believe that safety is paramount, and that no patient should ever have to wonder if the medicine they are dispensed is real. Cheaper medicine that comes with a worry about its safety is no medicine at all.
We hope you will join us in our advocacy for medicine safety. You can see our full set of advocacy positions in the document to the right.
PSM believes the safety of the drug supply chain is built upon its closed, regulated nature. Canadian drug importation is an idea that undermines the safety of the supply chain by involving vendors that cannot be regulated from overseas. Because it is opposed by Canada itself, it will certainly create a black market for medicine endangering American patients. PSM opposes foreign drug importation.
Background: Experts have concluded over and over again that importation is unsafe, unimplementable and and unlikely to save money. Learn why.
Watch our five minute video to learn the basics.
Read 2020 years of statements opposing drug importation.
Track dangerous importation plans in your state.
Deadly Counterfeit Pills
The latest wave of counterfeit pills has been flooding the U.S. since early 2015. PSM advocates on a variety of issues related to this wave of fake pills, including permanent scheduling of fentanyl and its analogues, regulations related to pill presses, and law enforcement resources to enable better enforcement and investigations.
Background: In July 2016, the DEA released an intelligence brief warning about counterfeit prescription pills made with fentanyl or its analogues. The pills were smuggled from Canada or Mexico or made by U.S. residents with powdered fentanyl and pill presses from China. They were killing Americans as early as 2015.
Fake Online Pharmacies
Since the late 1990's, counterfeiters and black marketers have been selling questionable medicines to U.S. residents via the internet. PSM advocates on a variety of issues to reduce the threat to Americans, including transparency and lock and suspend for domain names of counterfeit drug sellers and creating a duty to report illegal online drug information.
Background: Almost 95 % of online pharmacy sites selling to U.S. patients are out of compliance with U.S. laws and pharmacy standards, often selling drugs without valid prescriptions or from unknown sources.
These medicines reach medical practices, too. In 2012, the FDA found counterfeit cancer medication with no active ingredient. Over the next four years. it warned more than 3,000 U.S. doctors to stop buying discounted medicines from unlicensed foreign sellers.
Learn about the case against one of these drug sellers, Canada Drugs.
Consult our news archives for the latest about online pharmacies.